Technology
New On Robinhood
Health

Precision BioSciences

$9.37
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.54 (6.12%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell DTIL and other stocks, options, ETFs, and crypto commission-free!

About DTIL

Precision BioSciences, Inc. Common Stock, also called Precision BioSciences, is a biotechnology company, which engages in the development of genome editing technologies. Read More It operates through the Therapeutics and Food segments. The Therapeutics segment focuses on the development of products in the field of immuno-oncology and of novel products outside immuno-oncology to treat human diseases. The Food segment applies ARCUS, the company's propriety genome editing platform, to develop food and nutrition products through collaboration agreements with consumer-facing companies. The company was founded by Derek N. Jantz, Jeff Smith, and Matthew R. Kane in January 2006 and is headquartered in Durham, NC.

Employees
127
Headquarters
Durham, North Carolina
Founded
2006
Market Cap
471.89M
Price-Earnings Ratio
Dividend Yield
Average Volume
154.60K
High Today
$9.49
Low Today
$8.80
Open Price
$8.97
Volume
207.83K
52 Week High
$19.00
52 Week Low
$8.59

Collections

Technology
New On Robinhood
Health
Biotechnology
Food
Therapy
2019 IPO
US

DTIL Earnings

-$1.99
-$1.46
-$0.92
-$0.39
Q1 2019
Q2 2019
Estimated
-$0.49 per share
Actual
-$0.39 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.